Cho; Sun Jung
Patent Applications and Registrations
Patent applications and USPTO patent grants for Cho; Sun Jung.The latest application filed is for "method for treatment of degenerative brain disorders comprising inhibitor of sum01 and bace1 interaction as an active ingredient".
- Cho; Sun Jung - Gyeonggi-do N/A KR
- Cho; Sun-Jung - Chungcheongbuk-do KR
- Cho; Sun-Jung - Gyeongju-si KR
| Patent | Date |
|---|---|
| Dual antagonist for TNF-.alpha. and IL-21 for preventing and treating autoimmune diseases Grant 9,200,058 - Park , et al. December 1, 2 | 2015-12-01 |
| Method For Treatment Of Degenerative Brain Disorders Comprising Inhibitor Of Sum01 And Bace1 Interaction As An Active Ingredient App 20140186357 - Koh; Young Ho ; et al. | 2014-07-03 |
| Use of FLJ25416 gene Grant 8,486,905 - Won , et al. July 16, 2 | 2013-07-16 |
| Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases App 20130022642 - Park; Young Woo ; et al. | 2013-01-24 |
| Novel Use Of Flj25416 Gene App 20110008370 - Won; Misun ; et al. | 2011-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 